Primary urothelial carcinoma of the upper tract

Important clinicopathological factors predicting bladder recurrence after surgical resection

Wen Wei Huang, Hsuan Ying Huang, Alex C. Liao, Yow Ling Shiue, Hsiu Lun Tai, Chun Mao Lin, Yu Hui Wang, Ching Nan Lin, Kun Hung Shen, Chien Feng Li

Research output: Contribution to journalArticle

43 Citations (Scopus)

Abstract

The aim of the present study was to further characterize potential clinicopathological predictors for urinary bladder recurrence-free survival (UBRFS) in patients with primary urothelial carcinoma of the upper urinary tract (UUT-UC). The present series included 385 cases of surgically treated primary localized UUT-UC without previous or concurrent urothelial carcinoma of the urinary bladder. Among the 374 patients with follow-up information, clinicopathological features and therapeutic information including whether they received a laparoscopy-assisted nephroureterectomy (LNU) and adjuvant chemotherapy were correlated with UBRFS. After a median follow up of 69 months, 86 patients (23%) developed urinary bladder recurrence. The median time to develop urinary bladder recurrence was 12 months. At the univariate level, an increment in histological grade (P = 0.0321), a prominent papillary configuration (P = 0.0004), LNU (P = 0.0397) and male gender (P = 0.0401) significantly predicted an inferior UBRFS. At the multivariate level, increase of histological grade (P <0.0001, relative risk (RR) = 3.776), prominent papillary configuration (P <0.0001, RR = 3.244), and male gender (P = 0.0463, RR = 1.444) independently predicted UBRFS. In conclusion, male patients and those with high-grade and papillary UUT-UC, and who received LNU had higher risks of urinary bladder recurrence. Accordingly, for these patients, more intensive follow up coupled with postoperative intravesical adjuvant therapy to prevent urinary bladder recurrence should also be considered.

Original languageEnglish
Pages (from-to)642-649
Number of pages8
JournalPathology International
Volume59
Issue number9
DOIs
Publication statusPublished - Sep 2009

Fingerprint

Urinary Bladder
Carcinoma
Recurrence
Laparoscopy
Survival
Adjuvant Chemotherapy
Urinary Tract
Therapeutics

Keywords

  • Upper urinary tract
  • Urinary bladder recurrence
  • Urothelial carcinoma

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Primary urothelial carcinoma of the upper tract : Important clinicopathological factors predicting bladder recurrence after surgical resection. / Huang, Wen Wei; Huang, Hsuan Ying; Liao, Alex C.; Shiue, Yow Ling; Tai, Hsiu Lun; Lin, Chun Mao; Wang, Yu Hui; Lin, Ching Nan; Shen, Kun Hung; Li, Chien Feng.

In: Pathology International, Vol. 59, No. 9, 09.2009, p. 642-649.

Research output: Contribution to journalArticle

Huang, Wen Wei ; Huang, Hsuan Ying ; Liao, Alex C. ; Shiue, Yow Ling ; Tai, Hsiu Lun ; Lin, Chun Mao ; Wang, Yu Hui ; Lin, Ching Nan ; Shen, Kun Hung ; Li, Chien Feng. / Primary urothelial carcinoma of the upper tract : Important clinicopathological factors predicting bladder recurrence after surgical resection. In: Pathology International. 2009 ; Vol. 59, No. 9. pp. 642-649.
@article{44a2dfc186e04e92856e463f0db79c2c,
title = "Primary urothelial carcinoma of the upper tract: Important clinicopathological factors predicting bladder recurrence after surgical resection",
abstract = "The aim of the present study was to further characterize potential clinicopathological predictors for urinary bladder recurrence-free survival (UBRFS) in patients with primary urothelial carcinoma of the upper urinary tract (UUT-UC). The present series included 385 cases of surgically treated primary localized UUT-UC without previous or concurrent urothelial carcinoma of the urinary bladder. Among the 374 patients with follow-up information, clinicopathological features and therapeutic information including whether they received a laparoscopy-assisted nephroureterectomy (LNU) and adjuvant chemotherapy were correlated with UBRFS. After a median follow up of 69 months, 86 patients (23{\%}) developed urinary bladder recurrence. The median time to develop urinary bladder recurrence was 12 months. At the univariate level, an increment in histological grade (P = 0.0321), a prominent papillary configuration (P = 0.0004), LNU (P = 0.0397) and male gender (P = 0.0401) significantly predicted an inferior UBRFS. At the multivariate level, increase of histological grade (P <0.0001, relative risk (RR) = 3.776), prominent papillary configuration (P <0.0001, RR = 3.244), and male gender (P = 0.0463, RR = 1.444) independently predicted UBRFS. In conclusion, male patients and those with high-grade and papillary UUT-UC, and who received LNU had higher risks of urinary bladder recurrence. Accordingly, for these patients, more intensive follow up coupled with postoperative intravesical adjuvant therapy to prevent urinary bladder recurrence should also be considered.",
keywords = "Upper urinary tract, Urinary bladder recurrence, Urothelial carcinoma",
author = "Huang, {Wen Wei} and Huang, {Hsuan Ying} and Liao, {Alex C.} and Shiue, {Yow Ling} and Tai, {Hsiu Lun} and Lin, {Chun Mao} and Wang, {Yu Hui} and Lin, {Ching Nan} and Shen, {Kun Hung} and Li, {Chien Feng}",
year = "2009",
month = "9",
doi = "10.1111/j.1440-1827.2009.02420.x",
language = "English",
volume = "59",
pages = "642--649",
journal = "Pathology International",
issn = "1320-5463",
publisher = "Wiley-Blackwell",
number = "9",

}

TY - JOUR

T1 - Primary urothelial carcinoma of the upper tract

T2 - Important clinicopathological factors predicting bladder recurrence after surgical resection

AU - Huang, Wen Wei

AU - Huang, Hsuan Ying

AU - Liao, Alex C.

AU - Shiue, Yow Ling

AU - Tai, Hsiu Lun

AU - Lin, Chun Mao

AU - Wang, Yu Hui

AU - Lin, Ching Nan

AU - Shen, Kun Hung

AU - Li, Chien Feng

PY - 2009/9

Y1 - 2009/9

N2 - The aim of the present study was to further characterize potential clinicopathological predictors for urinary bladder recurrence-free survival (UBRFS) in patients with primary urothelial carcinoma of the upper urinary tract (UUT-UC). The present series included 385 cases of surgically treated primary localized UUT-UC without previous or concurrent urothelial carcinoma of the urinary bladder. Among the 374 patients with follow-up information, clinicopathological features and therapeutic information including whether they received a laparoscopy-assisted nephroureterectomy (LNU) and adjuvant chemotherapy were correlated with UBRFS. After a median follow up of 69 months, 86 patients (23%) developed urinary bladder recurrence. The median time to develop urinary bladder recurrence was 12 months. At the univariate level, an increment in histological grade (P = 0.0321), a prominent papillary configuration (P = 0.0004), LNU (P = 0.0397) and male gender (P = 0.0401) significantly predicted an inferior UBRFS. At the multivariate level, increase of histological grade (P <0.0001, relative risk (RR) = 3.776), prominent papillary configuration (P <0.0001, RR = 3.244), and male gender (P = 0.0463, RR = 1.444) independently predicted UBRFS. In conclusion, male patients and those with high-grade and papillary UUT-UC, and who received LNU had higher risks of urinary bladder recurrence. Accordingly, for these patients, more intensive follow up coupled with postoperative intravesical adjuvant therapy to prevent urinary bladder recurrence should also be considered.

AB - The aim of the present study was to further characterize potential clinicopathological predictors for urinary bladder recurrence-free survival (UBRFS) in patients with primary urothelial carcinoma of the upper urinary tract (UUT-UC). The present series included 385 cases of surgically treated primary localized UUT-UC without previous or concurrent urothelial carcinoma of the urinary bladder. Among the 374 patients with follow-up information, clinicopathological features and therapeutic information including whether they received a laparoscopy-assisted nephroureterectomy (LNU) and adjuvant chemotherapy were correlated with UBRFS. After a median follow up of 69 months, 86 patients (23%) developed urinary bladder recurrence. The median time to develop urinary bladder recurrence was 12 months. At the univariate level, an increment in histological grade (P = 0.0321), a prominent papillary configuration (P = 0.0004), LNU (P = 0.0397) and male gender (P = 0.0401) significantly predicted an inferior UBRFS. At the multivariate level, increase of histological grade (P <0.0001, relative risk (RR) = 3.776), prominent papillary configuration (P <0.0001, RR = 3.244), and male gender (P = 0.0463, RR = 1.444) independently predicted UBRFS. In conclusion, male patients and those with high-grade and papillary UUT-UC, and who received LNU had higher risks of urinary bladder recurrence. Accordingly, for these patients, more intensive follow up coupled with postoperative intravesical adjuvant therapy to prevent urinary bladder recurrence should also be considered.

KW - Upper urinary tract

KW - Urinary bladder recurrence

KW - Urothelial carcinoma

UR - http://www.scopus.com/inward/record.url?scp=68949107975&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=68949107975&partnerID=8YFLogxK

U2 - 10.1111/j.1440-1827.2009.02420.x

DO - 10.1111/j.1440-1827.2009.02420.x

M3 - Article

VL - 59

SP - 642

EP - 649

JO - Pathology International

JF - Pathology International

SN - 1320-5463

IS - 9

ER -